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Abstract: A common motivation for increasing open access to research findings and data is the
potential to create economic benefits—but evidence is patchy and diverse. This study systematically
reviewed the evidence on what kinds of economic impacts (positive and negative) open science can
have, how these comes about, and how benefits could be maximized. Use of open science outputs
often leaves no obvious trace, so most evidence of impacts is based on interviews, surveys, inference
based on existing costs, and modelling approaches. There is indicative evidence that open access to
findings/data can lead to savings in access costs, labour costs and transaction costs. There are examples
of open science enabling new products, services, companies, research and collaborations. Modelling
studies suggest higher returns to R&D if open access permits greater accessibility and efficiency of use
of findings. Barriers include lack of skills capacity in search, interpretation and text mining, and lack
of clarity around where benefits accrue. There are also contextual considerations around who benefits
most from open science (e.g., sectors, small vs. larger companies, types of dataset). Recommendations
captured in the review include more research, monitoring and evaluation (including developing
metrics), promoting benefits, capacity building and making outputs more audience-friendly.
Keywords: open science; open access; open data; economic impacts
1. Introduction
There has been a trend towards increasing openness in research practices in the United Kingdom
(UK) and internationally. There is now an expectation that, except under certain circumstances, UK
Research Council funded research will be published in open access format and that underlying data
will be freely shared [1,2]. The European Union has an extensive programme of work on open science,
including a declaration of open science principles [3] and a monitoring programme [4]. In the United
States, the Fair Access to Science and Technology Research Act requires publicly funded scientific
research to be made freely accessible online [5]. Open practices are expected to bring ‘significant
social and economic benefits’ ([1], p1), among other benefits [6]. However, while previous reviews
have touched on this topic [7,8], no systematic attempt has yet been made to identify and synthesize
evidence relating to this claim and present a clear picture of the economic impacts that open science
might have, how these comes about, and how benefits might be maximized.
The aim of this rapid evidence assessment (REA) is to bring together the best available evidence
to answer the question: What are the economic impacts of open science? It has the following specific
objectives:
• To identify the types of direct and indirect economic impact that open science has been empirically
demonstrated to have.
• To identify the mechanisms by which economic impacts come about.
• To identify the contextual factors that affect whether or not (and the extent to which) economic
impacts occur, and the extent to which the open science approach was a necessary condition of
their occurring.
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• To assess the magnitude and relative importance of different types of impact (positive and negative).
• To identify methods by which economic impacts have been (or have been suggested to be)
recorded and/or quantified, and how counterfactuals (i.e., non-open science approaches) have
been estimated.
• To identify policies (or other interventions including [but not limited to] clearer/better
communications about knowledge exchange and open science) which can help maximize the
economic benefits and reduce the costs associated with open science.
• To identify trade-offs between economic and other (e.g., academic, societal) impacts.
The term ‘open science’ has a broad range of meanings, ranging from the publishing of research
outputs (rather than keeping them confidential) to free sharing of every aspect of research including
protocols, analysis plans and notebooks [9]. Key elements are transparency, accessibility, sharing and
collaboration [10]. The scope of this rapid review if restricted to open access to research findings
(usually through open access publishing) and data (open research data), since these are the most mature
areas where there is likely to be the most evidence, and where funders’ requirements are currently
most explicit. Hereafter in this paper, I use the term ‘open science’ to refer to these concepts—but it is
important to bear in mind that the review does not capture all impacts that might be associated with
employing the full suite of open science practices.
The review takes in direct economic impacts in which open science has been a contributory factor,
including changes in productivity, competitiveness, employment, income, investment, and value.
The focus was on impacts in the economy in general, not those restricted only to the ecosystem around
scholarly communication (e.g., publishers, university library budgets, etc.), since the latter topic has
been widely considered in the context of the debate around transition to open access publishing.
Indirect benefits—such as increases in economic productivity through health improvements resulting
from new drugs developed with the contribution of open science outputs—are recognized as potentially
very important, but are out of scope. It is important to emphasize that economic impacts are certainly
not the only, or necessarily the most significant, area where open science has to the potential to make a
positive (or negative) contribution—access to knowledge and data has intrinsic and extrinsic benefits
that go well beyond this—but these impacts are also not considered in this review.
Before moving on, it is important to say a little more about the existing reviews, mentioned above,
which have touched on the question of economic impacts. These useful documents consider a broad
range of impacts associated with open science/access. But due to this breadth of coverage, they are able
to dedicate limited attention specifically to economic impacts. Study [7] by ElSabry focuses on societal
impacts in general, such as the use of research findings by policymakers and practitioners. While it
includes some mention of economic questions, they are not given explicit or focused consideration.
While basic methodological details of the review are provided it is not possible to tell how studies
were identified or data extracted. Study [8], by Tennant et al., provides a broad review of academic,
economic and societal impacts of open access to research findings. While some consideration is given
to economic impacts on non-publishers (which is the main focus of the current review), this is limited to
a few paragraphs, and the process by which documents were identified for the review is not described.
There is therefore a need for a focused, systematic attempt to identify evidence for economic impacts
of open science.
In the next section, I describe the systematized review method, and then go on to present
results of the review. I break these down into sections on methods employed to assess economic
impacts, the impacts themselves (broken into benefits and costs/challenges), contextual factors, and
recommendations made in the reviewed material. I finally draw conclusions and make a number
of recommendations.
2. Materials and Methods
An REA is a review that uses systematic review methodology to map the characteristics of what
is already known about the research topic, and supports decision making by providing evidence on
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topics of policy interest and identify gaps in research (Supplementary Materials). They can be limited
in focus to fit with resource constraints and policy timescales, and are now quite widely employed in
UK policymaking (e.g., see [11,12]). The main advantages over non-systematic reviews are the level of
objectivity they provide as to what should be included, and the increased confidence they give that no
important evidence has been missed.
In conducting an REA, there must be a trade-off between the breadth of material which it is
possible to cover and the comprehensiveness of the review within given resources. Conducting a
systematic and comprehensive review in a narrow area can be preferable because this allows us to say
with greater confidence that no key evidence has been missed in the area of focus, and it is subsequently
possible to keep this review up to date without having to revisit older material to check for gaps.
The scope can be expanded in future as resources become available, again without having to back-track
over previously reviewed material.
For this reason, alongside others described in the previous section others described above, this
focused predominantly on the economic impacts of free dissemination of research methods and
results (open access publishing) and of research data (open research data). Pilot searches suggest that
performing a comprehensive review in these subjects will be possible with the resources available, but
that adding other relevant subjects (such as open source software for research) substantially expands
the amount of material to review. However, where relevant evidence was encountered during the
course of a search focused on open access/data (for example, where specific open source software is
required to make use of open research data), it will be recorded. For the avoidance of doubt, evidence
dealing with open data that is not primarily generated for research purposes is out of scope.
REAs require a protocol to be set out in advance specifying how material will be located, what
criteria will be used to assess whether it will be included in the review, what information will be
extracted from included sources, and how this will be synthesized. The original protocol for this review
is available at https://osf.io/jd3eb. Administrative restrictions meant that it was not possible to share
this protocol publicly at the time of the initial review. However, input was sought from a number of
leading experts in the open science domain and their recommendations incorporated.
The remainder of this section describes the process that was followed, and highlights any
departures from the original protocol, along with a justification. I follow the PRISMA guidelines [13]
as closely as possible.
2.1. Search, Screening and Quality Assessment
The search strategy specifies how the source material for the review was identified. This was
achieved through a combination of online searches, citation checking and expert consultation. Online
searches require the concepts of interest to be specified, and then operationalized for use in a search.
Table 1 shows the concepts and search terms that have been identified, and shows an illustrative search
string for the Scopus database.
The searches are focused on title/abstract/keywords of articles to increase the proportion of hits
likely to be directly related to the subject in question, in the knowledge that some relevant results may
be missed. Pilot searches indicated that expanding searches to the full text of documents would lead to
an unmanageably large number of hits. The search term “open access” has been qualified in the search
to minimize the number of results referring to articles that themselves are open access (where the
words “open access” often appear in the copyright statement with the abstract). At the protocol review
stage, a number of additional search terms were suggested, including abbreviations CBA and BCA,
and terms such as “general equilibrium models”, “return on investment” and “growth accounting”.
All searches were recorded and are available to view in Appendix B.
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Table 1. Construction of database search terms.
Open Science Economic Impact
Concept
Open science
Open data
Open research data
Open access
Open metrics
Economic impact
Financial impact
Monetary impact
Cost/benefit analysis
Input-output
General equilibrium modelling
Return on investment
Growth accounting
Search term
“open scien*”
“open data”
“open research data”
“open access” W/1 publ* OR paper* OR journal* OR book*
“open metric*”
econom*
financ*
cost*
mone*
cba
bca
“input-output”
“general equilibrium”
“return on investment”
“growth accounting”
Scopus
example
TITLE-ABS-KEY (“open scien*” OR “open data” OR “open research data” OR (“open access” W/1
publ* OR paper* OR journal* OR book*) OR “open metric*”) OR TITLE (“open access”) AND
TITLE-ABS-KEY (econom* OR financ* OR cost* OR mone* OR cba OR bca OR “input-output” OR
“general equilibrium” OR “return on investment” OR “growth accounting”)
This search strategy was deployed on the following databases which permit Boolean searching:
• Scopus
• Web of Science (all databases)
• ScienceDirect
The following sources were also searched based on combinations of the above search terms.
• JISC
• UK Government website (gov.uk)
• Innovate UK
• UK Research Council and HEFCE websites
• Google scholar (searches of title only, limited to review of first 300 results [14])
• Open Data Institute
• Digital Curation Centre (DCC)
• Nesta
• Centre for Open Science
• Open Research Funders Group
• Open Scholarship Initiative
• Open Access Bibliography
• Open Access Directory
• Universities UK
• OECD Library
• Europa.eu
• European Universities Association
All hits from database searches were downloaded and imported into reference manager software
(Zotero v5.0, George Mason University, Arlington, VA, USA). For searches of other sources, results
were downloaded where the title and/or initial screening suggests that the document is likely to meet
the inclusion criteria. In some cases, where Google was employed to search for sources, results were
restricted to PDF documents. This is because pilot searches revealed that without this restriction,
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an unmanageably large number of general (e.g., news page) results were often returned. Reports of
empirical research were almost always found to have PDF version available. While this approach risks
missing sources, it was considered justified given that other forms of source identification (such as
citation checking and expert elicitation) were also being employed, and given the significant time
savings it allowed. All documents so far identified as part of the work of the Open Science team
were also be captured through a review of internal documents. Two informal discussions were also
conducted with experts in the field, and any sources they recommend were captured1. As the original
searches were conducted in late 2017 with an informal update in early 2018, a limited number of further
update searches were conducted during the final preparation of this paper in April 2019.
All references were imported into the systematic review management software EPPI-Reviewer 4
and de-duplicated. They were then screened by a single reviewer on the basis of the inclusion/exclusion
criteria set out in Table 2. A first-pass screening done on title/abstract, with a second screening on the
full document.
Table 2. Inclusion and exclusion criteria.
Include if Source Exclude if Source
Is in English Is not in English
Includes discussion or analysis of making research
methods/findings freely available (open access publishing).
AND/OR Includes discussion or analysis of making research
data freely available (open research data).
Does not include discussion or analysis of the economic
impacts of making research methods, findings or data
openly available.
Includes explicit consideration (informed by empirical
evidence) of direct or indirect economic impacts (with or
without quantitative value estimates).
Does not explicitly consider economic impacts based on
empirical evidence.
Only considers open source software without discussion
of open data or open access publishing.
Reports work in an open access publication or based on
open data, but is not explicitly about these concepts.
Focuses only on impacts within the scholarly
communications ecosystem of publishers, universities
and research funders2.
Only considers open data in general, as opposed to
specifically research data.
The reference lists of all documents still included at this point were checked, and any relevant
documents referred to were also loaded into EPPI-Reviewer and passed through the screening process.
The final list of included documents was reviewed by a number of colleagues, who were invited to
suggest documents which may have been missed—these were screened for inclusion. Any documents
which came to my attention at any point were also loaded in and screened. A flow chart showing this
process, and the numbers of records retained/removed at each stage, is included in Section 3.
Quality assessment was conducted to ensure that poor quality studies are not given undue
weighting when synthesizing evidence. Because of the exploratory nature of this review, no sources
were completely excluded on the basis of quality. The TAPUPAS framework was employed to aid
assessment of quality, with sources graded on each point from poor (0 point) to good (2 points) (original
protocol stipulated a 1–5 points scale, but this was subsequently considered unrealistically precise).
It was also anticipated that for any full economic impact assessments located, the EPPI-Centre data
extraction form (economic) Section 7 items would be used for quality assessment. In the event, this
more detailed approach was not feasible given project resource constraints.
1 These interviews will also be used to inform and refine the case study objectives and interview schedules.
2 This criterion was added after the protocol was finalised as many documents were identified in this category and, as set out
in the introduction, such impacts were not the focus of this review.
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2.2. Extraction
Data on the following criteria were extracted from all included sources:
• Organizational affiliation of authors
# Academia
# Industry
# Governmental
# Other non-governmental
• Study country
• Funding source (if applicable)
• Coverage
# Open access publishing
# Open research data
# Other
• Key aims
• Data collection and analysis methods
# Interviews
# Social surveys
# Macroeconomic modelling
# Cost–benefit analysis
# Case study
# Other
• Key findings (on economic impact)
• Relevant policies cited
• Recommendations
• Quality assessment (scored 0–2)
# Transparency
# Accuracy
# Purposivity
# Utility
# Propriety
# Accessibility
# Specificity
Additional coding of extracted information was conducted in NVivo (qualitative analysis software)
to allow identification of key themes.
2.3. Synthesis
The results were synthesized under headings aligned with the review objectives presented above.
For each objective, a thematic analysis approach was used. For example, to describe the types of
economic impact identified in the review, specific examples were collected together under broad
common themes (such as ‘labour cost savings’). Impact themes were associated with quantitative data
where possible (e.g., where examples of financial costs, job growth/destruction, etc., can be allocated
under themes). Themes were also be identified in contextual factors, and any consistent associations
with economic impacts highlighted (a statistical analysis was not possible).
Publications 2019, 7, 46 7 of 30
2.4. Updating
The original review conducted over late 2017 and early 2018. It was therefore updated prior to
preparation of this paper in April 2019, by repeating a subset of the original searches, restricted by date
to 2018 and 2019 (see Appendix B). Documents identified during this process were screened and data
extracted according to the process described above.
2.5. Description of Results
The following sections present the results of the review, including a summary appraisal of methods
used in the studies which were identified, the benefits and challenges they uncovered (with value
estimates where available), a consideration of contextual factors that may be relevant to the results, and
a summary of recommendations made in the sources to support benefits maximization. In presenting
this kind of synthesis, it is important to bear in mind that the detailed sources that were drawn on
often include caveats and contextualization which it is neither possible nor desirable to capture in full.
I attempt to detail the main limitations or contextual points where relevant. Please note that these
sections also refer to additional literature, beyond that identified in the review, where it can help add
useful context or additional information.
3. General Review Summary
Figure 1 shows a flowchart of the REA, including number of documents included/excluded at
each stage.
The original review identified 20 documents for detailed extraction, with updating providing
one additional document, leading to a total of 21. There was substantial variety in the type of
study identified, which can present challenges for quality assessment. A quite flexible QA method
(TAPUPAS3) was selected in anticipation of this, and ultimately two studies were de-prioritized on
the basis of insufficient methodological detail, or justification of findings/conclusions. A further five
documents did not present new empirical evidence but were still included because of their relevance
to the review questions (for example, one study presented a possible research method).
Five sources described studies focusing specifically on the UK, while the remainder focused on the
USA, Canada, Denmark, Finland, or more than one country. All but seven of the sources were published
in or after 2014. There was a roughly even balance in coverage between open access publishing
(eight sources) and research data (nine sources), with six sources also including consideration of other
open science topics. As indicated in the previous section, the review identified a lot of work has been
done on the economics of open access publishing, but the vast majority of this focuses on the impacts
within the university/publisher/funder ecosystem rather than the broader economy, and was therefore
not included.
There was a high concentration of included studies around certain researchers or research
approaches. John Houghton, for example, was involved as co-author in six, and many of these studies
used similar research approaches. Furthermore, because these studies draw on more diverse evidence
sources in comparison to some other included documents (often, for example, combining interviews,
surveys and desk research to inform economic analysis, rather than presenting only interview evidence),
and more explicitly focus on questions of economic value of open science, they are drawn upon
comparatively more heavily in this review. A table summarizing the main aims and methods of each
included study is included in Appendix A.
3 https://www.scie.org.uk/publications/researchmindedness/findingresources/assessingresearchquality/.
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4. Methods for Assessing Economic Impacts
The review uncovered a diverse range of approaches to gauging the economic impacts of open
science. This is likely related, to some degree, to the difficulty in tracking the usage of open science
outputs outside of the academic context (where citation practices make this more achievable). Often,
users leave no footprint when they access open science outputs, and it there is often no requirement to
declare usage. It is possible (although there is no evidence to support this) that firms may perceive it to
be beneficial to conceal their use of open findings and data if they believe they derive an advantage
from using resources or approaches that competitors may not be aware of. Even if usage is apparent, it
is still often difficult to attribute specific economic impacts to the openness of the outputs.
This section sets out the range of ways in which researchers have attempted to combat these
challenges and provide value estimates. Principally, these involved using surveys/interviews to elicit
user information and opinion, and cost–benefit analysis, sometimes informed by modelling approaches
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(based on desk research on costs/benefits, user input and assumptions). These may be conducted
either in the context of a specific case (such as a research collaboration of data repository) or applied
more generally (such as at country level). Often, several approaches are combined in the same study.
The methodological heterogeneity makes it harder to draw comparisons between findings of separate
studies than if standard approaches were employed.
4.1. Question-Based Approaches
Where it is difficult to measure revealed behaviour (such as observing actual use of open science
outputs), it is common to ask users about their usage instead. In their evaluations of UK data
repositories [15] and the European Bioinformatics Institute [16] (along with evaluations in other
countries not included here), Beagrie and Houghton used surveys and interviews for this purpose.
Interviews were used to help develop the survey content, such as by suggesting which kinds of
cost–benefit to include questions about. They also permit more in-depth and detailed insight into
how costs or benefits might come about. Interviews are usually only possible with relatively small,
non-random samples of participants, and are therefore not suitable for making generalizations to wider
populations on, for example, proportions of users affected by certain issues. Interviews were employed
in a number of other studies in the review [17–21].
The Beagrie and Houghton surveys asked users to make estimates of factors such as the time
spent preparing data for upload, time spent working with data they had downloaded, and the extent
to which they would be able to perform their work without access to the open data. Answers to such
questions, combined with estimate of salary costs, permit insight into investment in preparing/using
open data (known as Investment Value). Among other questions, the surveys also asked users to
estimate how much they would be willing to pay to access the (currently free) services, or be paid to
forfeit access (willingness to accept). These Contingent Valuation approaches permit estimation of the
value placed on free services—with willingness to accept potentially giving insight into value to users
whose budgets would prevent them suggesting a high willingness to pay. Subtracting willingness to
pay from use value (in a welfare approach) gives insight into consumer surplus. The main drawback
with surveys is that it is hard to know how far responses reflect ‘objective reality’. For example, in the
Beagrie and Houghton work discussed above, respondents were asked to assess how far having access
to data in a repository affected their work efficiency (on a percentage scale). Even when pilot testing
has been done, it is unlikely that all respondents would interpret such a question in the same way, or
be able to come up with an accurate estimate (or even to know exactly what efficiency would mean in
this context). The authors are keen to highlight such limitations, but it is easy for such caveats to get
lost when key findings are extracted from their context. Surveys were also employed by other studies
in the review [18,21].
4.2. Cost–Benefit Analysis (and Similar) Approaches
In the studies reviewed, data from surveys and interviews was often combined with information
and assumptions based on desk research to inform variants of cost–benefit analysis (CBA). In a standard
CBA, researchers sum up the identifiable existing or expected costs and benefits (converted to monetary
terms) to which stakeholders in the system of interest are exposed to calculate the overall costs and
benefits which accrue, and to whom. For example, in an evaluation of the Human Genome Project,
Battelle were able to calculate the value of additional employment provided by the collaboration
and organizations connected with it, including the tax revenue this yielded [22]. Assessments of
the value of open access publishing such as those by Houghton et al. [23] and CEPA LLP and Mark
Ware Consulting Ltd. [24] use best estimates of costs in the existing system and then use modelling
approaches to suggest how these might change under alternative publishing models. In their study of
the value of text mining (including consideration of the benefits of open access to this), McDonald and
Kelly [17] drew on CBA techniques recommended in HM Treasury’s Green and Magenta Books (on
appraisal and evaluation in central government), and Orange Book (on the management of risk).
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This CBA-like approach such as that used in CEPA LLP and Mark Ware Consulting Ltd. [24]
sheds useful light on costs/benefits within the scholarly communication ecosystem, but not the wider
impacts on the economy. Multiple works by Houghton and others (for example, see [23]) therefore
include an additional modelling step. They employ a modified Solow–Swan model, which is a way of
estimating the contribution of technological progress (driven by R&D) to economic growth. It can be
used to estimate a return on investment in R&D through value to the economy in the coming years.
In the sources reviewed, the model is modified to include consideration of the accessibility of R&D
outputs (i.e., the extent to which they are available to inform technological progress) and efficiency
with which R&D expenditure is converted into technological development (which could be potentially
be improved by open science practices which help reduce redundancy or improve replicability—see
next sub-section). The modified model does not tell us anything about the real extent to which open
science approaches could improve accessibility of efficiency (these are based on assumptions), but
does provide an indication into what different levels of accessibility/efficiency improvement might
mean for value in years to come.
While studies of open access publishing tend to focus on estimating costs/benefits across the
sector, much of the empirical evidence on economic impacts of open science more broadly is collected
in the context of case studies. For example, this includes studies of research collaborations such as
the European Bioinformatics Institute [16], the Structural Genomics Consortium [25], the Research
Collaboratory for Structural Bioinformatics Protein Data Bank [26] or of data repositories such as the
Economic and Social Data Service [27]. As well as making estimates of the general value of these
initiatives using the techniques described above, such evaluations frequently include sub-case studies.
In the case of the EBI, for example, part of the work involved conducting impact case studies on specific
companies which have been involved in the initiative. By pulling out findings from the research for
specific named companies, the research reveals concrete examples of how impact comes about. While
the generalizability of such examples is limited, they do serve to illustrate when specific routes to
impact are working, or to highlight routes which may otherwise not have been anticipated.
Other approaches employed in evaluation of impacts of open data in general have looked even
more broadly at its possible impacts, including consideration of Social Return on Investment (proposed
approach only) [28] and wide ranging economic analysis (by McKinsey) of value to sectors such as
education, healthcare and oil/gas [29]. This analysis looks at issues such as, in the transportation sector,
improved infrastructure planning and management, optimized fleet investment and better-informed
consumer decision-making. Specific details of the McKinsey calculations are not provided, but
they result in very high value estimates ($3 trillion per year to the global economy). Nevertheless,
another open data report for the G20 considers that the McKinsey estimates could even prove to be
underestimates [30]. It is important to note that open data in general tends to differ from open research
data in ways that are relevant to economic impacts—see subsection on contextual considerations, below.
5. Economic Impacts
The review identified a variety of ways in which economic costs and benefits associated with
open access to research findings and data, and a number of value estimates. These are set out in the
following section. The benefits part is separated into two broad routes—efficiency and enablement.
• Efficiency means getting the same output from research or innovation for less input (principally
public research funding). For example, if open access publishing can be shown to allow access to
research findings for the same number of researchers for a lower overall cost, this would represent
an efficiency saving. While this review is not principally concerned with economic impacts within
the university/publishing sector, such efficiencies are also relevant to wider economic impacts
through improved returns to R&D.
• Enablement signifies ways in which open science approaches have led to economically impactful
activities which would have been less likely to occur in a closed environment.
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The remainder of this section presents evidence on efficiency and enablement benefits, costs and
challenges, contextual issues and the recommendations made by the authors of the documents reviewed.
5.1. Efficiency
The main identified efficiency benefits come about in the form of access costs savings, potential
for labour cost savings (or productivity improvements), and other benefits such as reduced transaction
costs. This sub-section explores evidence for these benefits in more detail.
5.1.1. Access Cost Savings
Under a closed model, if a user wants to have access to certain findings or data, they must
either pay for that access, or pay to create the findings/data themselves. There is suggestive evidence
of savings potential associated with both open to research findings and data. Such savings would
accrue both to public funders of research (as researchers are large consumers of research outputs) and
commercial users.
Research for Jisc in 2011 [31] found that more than two–thirds (68%) of researchers in UK
universities and colleges felt they did not have access to a sufficiently wide range of journals and
conference papers; only 18% of researchers in industry/commerce felt themselves to have similarly
limited access. However, for those participants who viewed having access to journal papers as
important, a quarter of those in industry/commerce described their current level of access as fairly/very
difficult, compared to just 5% in universities and colleges. The main barrier to access was unwillingness
to pay. Research on access to research outputs in Denmark [18] found examples of companies resorting
to workarounds such as establishing formal/informal relationship with university researchers and
students to gain access vicariously, or physically going to university library buildings to use their
terminals for access.
Houghton and others [23] summed the costs and savings associated with accessing research
findings (e.g., production, publishing, dissemination) under open or paid access models. According to
their analysis, open access approaches would have been £813–1180 per journal article cheaper than toll
access, equating to £80–116m per year (in 2007) for the UK higher education sector, and with similar
potential levels of saving relating to book publishing. These figures are disputed, however—especially
by those analysts who question the accuracy of the publishing cost estimates [32,33]. This and other
analysis [24] have informed the UK’s current policy position which is to move towards open access
publishing models. Recent research for Universities UK suggests that the costs of transitioning to open
access are being impacted by increases in Article Processing Charges [34], which might be expected to
negatively impact the net benefits.
Research data, unlike publications, has not tended to be accessed by organizations on a
subscriptions basis, so a similar analysis is not really useful in this area. However, recent years
have seen a move towards the development of data repositories, where datasets can be accessed for free
by most users with no or minimal registration requirements. Beagrie and Houghton conducted studies
in an attempt to evaluate the savings that arise to users through having access to such repositories. These
include the Economic and Social Data Service (ESDS, now integrated into the UK Data Service) [27],
the Archaeology Data Service (ADS) [35], the British Atmospheric Data Service (BADS, now part of
the CEDA Archive) [36] and the data repositories curated by the European Bioinformatics Institute
(EBI) [16]. It is important to note that some of these repositories do not only include open research data,
but also a substantial quantity of open government data. The values included below do not distinguish
between the different sources of data, so will overestimate the value connected with (solely) research
data. Access to most UK Data Service data is only free for research and teaching purposes; commercial
users are required to pay.
The authors used surveys to ask users (mostly from the research sector) of these services what they
would pay to retain access (willingness to pay), and what payment they would accept for loss of access
(willingness to accept). They also asked users to estimate how much time they spent using the service
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(and preparing data to submit to it), to which it was possible to apply a labour cost. As highlighted in
the section of this paper considering methods, getting an accurate estimate of willingness to pay/accept
from surveys can be difficult for reasons including respondents’ own difficulties in estimating value,
incentives to obscure true value estimates, and mismatch between valuations and real purchasing
behaviour [37].
These caveats accepted, in the case of the ESDS they found a consumer surplus of £21m per
year—that is, users expressed willingness to pay £21m more than the £4m they were currently investing
in labour costs to use the service. Given the cost of running the service of roughly £3m per year, this
equates to a net economic value of £18m per year, or more than five times the cost of running the
service. A similar study on the European Bioinformatics Institute suggests that users’ willingness to
pay, at around £322m, exceeded the annual operational budget of around £47m by approximately six
times. A study which employed similar methods to estimate the economic impact of the Research
Collaboratory for Structural Bioinformatics Protein Data Bank also found large positive returns—for
example, contingent value (or hypothetical willingness to pay multiplied by number of users estimated
on the basis of website visits) was more than 100 times greater than the project’s annual operating
cost [26]. It should, however, be noted that this study relies extensively on assumptions based on
previous valuation work.
Measuring users’ willingness to pay can underestimate the value they attach to a service where
those users are quite resource constrained. This was the case for the ADS, where users’ willingness
to pay for the service was sufficiently low that the consumer surplus and net economic value were
negative. The authors argue that in some cases (for example, in sectors where funding is relatively
scarce) it is more instructive to focus on users’ willingness to accept payment for lack of access, which
has no resource constraints. If this is used instead of willingness to pay, a net economic value for the
service of roughly eight times the £700k operational budget is achieved. The authors note a similar
resource constraint for users of the BADC, although in this case their stated willingness to pay still
suggests a positive net economic value of just under £1m, on an operational budget of just over
£2m. These specific examples illustrate the challenges in providing anything more than very general
indications of the potential economic impact of free resources, and provide (at best) limited evidence
for benefits potential.
As well as reducing direct costs associated with access to research outputs, open science approaches
can help reduce transactions costs. The Structural Genomics Consortium is a collaborative research
body that aims to support drug discovery by sharing open access information on pre-competitive
biological structures4. An evaluation of its work found that its open collaborative approach avoided
the direct and labour costs of establishing multiple material transfer agreement between partners [25].
Another study has estimated that the costs of such agreements for a single collaboration can run into
the hundreds of thousands of dollars [38], so given the extensive collaboration (between hundreds of
facilities) that the SGC has enabled, this element of saving is likely to be considerable.
Transaction cost savings are also likely to arise for text/data mining uses. Under normal
circumstances, those intending to text/data mine are required to reach agreement for such usage with
multiple publishers and content providers [17]. The introduction of a text and data mining copyright
exception has reduced this burden for non-commercial uses, but commercial use is still restricted
and there are other barriers related to mass downloading of material and sharing of outputs [39].
Campaigns are underway at the EU level to address such issues [40]. As well as the costs and time
required to reach such agreements, it also introduces significant uncertainty into such projects as it
is possible that some agreements may not be reached. Open access approaches have the potential to
mitigate such costs5.
4 https://www.thesgc.org/about/what_is_the_sgc.
5 Please note, however, that no financial estimates were discovered for the scale of such savings.
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5.1.2. Labour Cost Savings or Productivity Improvements
It takes time for firms and researchers to actually access research outputs, and this time is reflected
in labour costs. It can take longer for people to access closed research outputs than when access is open.
A survey in Denmark by Houghton, Swan and Brown found that knowledge-based SME employees
spent on average 51 min to access the last research article they had difficulty accessing, and this rose to
63 min for university researchers [18]. Given they reported difficulty accessing 17 articles per year, the
cost of such delays based on average staff salaries could amount to €70m (although the authors note
that their sample was not representative)6. This is a cost that could, in theory, be saved if all access
barriers were removed. However, the actual time saving associated with open access was not tested.
Support was also found for this potential saving in an interview-based study by Parsons et al. [19].
The data repository evaluations by Beagrie and Houghton referred to above also attempted to
estimate the time savings that accrued to users of the repositories. This was done by asking them to
estimate how many hours they spent working with repository data (to which a value could be attached
based on average salaries), and to use a percentage scale to estimate how much more efficiently this
allowed them to use their time than if the repository were not available. This is clearly a difficult
assessment to make, and the researchers report problems associated with participants interpreting
the questions in different ways. However, open-ended response fields allowed some insight into
this interpretation—for example, users taking into account reduction in form-filling, traveling to
on-site/supervised repositories, and efficiencies associated with the format of the data. Using these
responses, the researchers suggest that there may be efficiency gains worth £68–100+m per year for the
ESDS, and smaller but also positive savings for ADS (£13–58m) and BADC (£10–58m)7. They estimate
the equivalent savings for the EBI at approximately £1–5 billion, at least 20 times more than the direct
operational cost.
As well as making individual research outputs easier to access, open access can also facilitate text
and data mining, which allows generation of new information through analysis of large bodies of text
or data. One of the key benefits of this is that time taken to extract useful information from sources can
be reduced (compared to manual approaches). It is difficult to estimate what the level of time saving
might be, but McDonald and Kelly suggest the following [17]:
If text mining enabled just a 2% increase in productivity corresponding to only 45 min per academic
per working week, this would imply over 4.7 million working hours and additional productivity worth
between £123.5m and £156.8m in working time per year.
It should be noted that some applications of text and data mining, such as filtering and presenting
only relevant research to users, risk negative consequences such as missing key evidence unless a
substantial proportion of available content is available for mining.
5.1.3. Other Efficiency Benefits
There are a number of other ways in which open science could lead to more efficient research,
and therefore more positive economic impact. It is estimated that closed research can lead to high
levels of duplication—that is, where separate teams work on the same thing unbeknownst to each
other. While the closed nature of the research inherently makes the extent of this hard to estimate, an
analysis of pharmaceutical patents by 18 large companies showed that 86% of target compounds were
investigated by two or more companies [41]. It is important to draw a distinction between duplication
and replication (the latter of which can help increase confidence in conclusions); duplication is a
problem because multiple companies may invest in developing a compound (or other innovation)
that has already been demonstrated to be ineffective [42]. Redundancy in research goes wider than
6 For comparison, UK GDP is approximately 8.5 times that of Denmark.
7 Please note that the authors emphasize that, because of some differences in the way these figures were calculated between
studies, they are not directly comparable with each other.
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questions of open science and is connected with challenges such as general under-publication of ‘null’
results [43]. However, open approaches such as pre-registration of trials could help ameliorate the
situation, in this case by helping to reduce suppression of ‘null’ results and therefore potential for
wasteful duplication of approaches which have been shown to be ineffective. Text and data mining
could also make it easier to identify previous findings [17]. The challenge of decreasing research
productivity has been highlighted [44]; the above factors have the potential to mitigate this.
So far, the evidence has focused on efficiency, or doing the same with less input. The implication
here, for example, is that firms are able to access research findings and data in closed situations, but
just at higher financial and other resource costs. However, there are also mechanisms by which an
open approach can enable access, connections and collaborations that would not have happened, or
would have happened more slowly, otherwise. This is the subject of the next section.
5.2. Enablement
Enablement benefits come in the form of new products, services, companies and collaborations,
as well as permitting work that could not otherwise have been undertaken.
5.2.1. New Products/Services/Companies
It has been suggested that open science approaches have the potential to lead to the development
of new products, services, companies and even industries [30,45]. This review did not reveal any
economy- or even industry-wide attempts to estimate the extent to which this has taken place. However,
it did identify a number of case studies that demonstrate the existence of such mechanisms and provide
some insight into the circumstances under which they come about. These examples are all drawn from
the life sciences (see section on contextual issues below for further discussion of this).
Probably the largest project to make research data openly available was that Human Genome
Project, which ran from 1990 to 2003 and was funded principally by the US government (at $3.8 billion).
Data were made publicly available within 24 h of discovery [46]. The availability of the human genome
has led to the development of new diagnostic tests and technologies, and informed many new disease
treatments and treatment approaches [46]. For example, use of genetic information has informed new
tests which allow anticipation of the likelihood of adverse reactions—this reduces harm to vulnerable
patients, while allowing effective drugs to continue to be used in people to whom they do not pose a
risk [22]. Further products and services have been enabled in a range of domains, from agriculture and
environment to forensics and industrial biotechnology. An economic impact assessment of the project
found that it generated ‘an economic (output) impact of $796 billion, personal income exceeding $244
billion, and 3.8 million job-years of employment’ (pES-2) [22].
Because that report does not focus on the ‘openness’ of the project in particular, it does not permit
assessment of how the benefits would have compared under a more closed model. However, other
research has taken advantage of the fact that a parallel, comparatively closed sequencing effort (run
by the firm Celera) yielded data with some IP protection [47]. It estimates that ‘Celera’s IP led to
reductions in subsequent scientific research and product development on the order of 20–30 percent’
(p. 24), a result of the additional transaction costs that using Celera data would impose. This finding is
caveated that this may not represent research effort that was ‘lost’—it may simply have been focused
on non-Celera genes.
There are examples of new products and companies emerging from other, similar projects.
The Structural Genomics Consortium is a not-for-profit public private partnership which conducts
research on protein structures, releasing structural data freely and without patent protection [48].
An evaluation found that about half of a small sample of researchers surveyed (17 respondents)
believed that their research would lead to development or trialling of a pharmaceutical product in
future, and three people reported that their research already had this outcome [25]. A good example is
JQ1, a compound that research through the Consortium suggested may be used to inform development
of cancer treatments. Following this discovery, GlaxoSmithKline started its own proprietary research
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programme which led to a clinical trial within two years [49]. Research that later compared the number
of patents connected to the JQ1 discovery found that after four years, 105 patents had been filed,
compared to a mean of 29 for two similar compounds which were not released openly [50]. Three
spin-out companies have resulted from the work of the SGC, with one, Tensha Therapeutics, connected
with JQ1 [49]. It received $15m initial investment, and was acquired within a year (by Roche) for
$535m [51].
5.2.2. Collaborations
As before, it is not always clear that new products or companies would not have appeared had the
originating project not been open in nature. However, the experience of the SGC points to an additional
benefit that such open models can yield that means that research can happen that may not have
done otherwise—that of new pre-competitive multi-stakeholder collaborative research. A case study
of the consortium [52] highlighted the potential conflicts that can arise in standard university–firm
partnerships, such as firms’ desire to appropriate knowledge outputs running counter to academics’
requirement to publish openly, or for universities to make their own IP claims. The SGC managed this
in a variety of ways, such as by revealing lists of target proteins without attaching companies’ identities
to them (so protecting companies’ research interests), and not revealing the list of targets publicly.
Instead, protein structures were released only when resolved. By providing such assurance—identified
as ‘meditated revealing’ and ‘enabling multiple goals’—the SGC was able to attract funding from
the Wellcome Trust, GlaxoSmithKline, Novartis, Merck, government organizations and other smaller
foundations. In 2011, the consortium reported the addition of two new members, including Pfizer, and
that together the consortium members were committing $50m for the next four years of research along
with $9m in-kind contributions [53]. Another major open collaboration is in its early stages at the
Montreal Neurological Institute and Hospital [54]. While no evaluation is yet available of its impacts,
an evaluation plan is in place which will also look more broadly at impacts of open science approaches
internationally, potential for new metrics, and other relevant questions [55].
Open science collaborations are also appearing in other subject areas, such as the SPOMAN (Smart
Polymers and Nano-composites) project at Aarhus University [56]. In this case, the focus is more
on collaborative ideation, with partner companies being involved in determining research priorities.
The research is focused on fundamental knowledge and partners may not patent it. Instead, all outputs
(included data, code and lab notebooks) are shared openly, with companies being free to file patents on
specific applications of the findings. No economic evaluation is yet available on the project.
5.2.3. Permitting Work
A key enabling contribution of open science outputs can be to permit further research that would
not otherwise have been possible. For example, the evaluation of the European Bioinformatics Institute
found that 45% of survey respondents could not have either found the data they access through
the repository themselves, not created it themselves [16]. Work based on this data can therefore be
viewed as additional to what would have occurred had the Institute not existed (although any such
counterfactual must take into consideration how funding for the Institute might otherwise have been
deployed). A similar proportion of survey respondents to the Economic and Social Data Service
evaluation reported this also (330 out of 894, 37%) [27].
It has also been suggested that enhanced text- and data-mining capabilities permitted by open
approaches (as outlined above) can result in previously hidden connections between different areas of
research being unveiled [17]. The example is provided of a tool which was used to analyse disjoint
biomedical literatures to identify possible new disease targets for the drug thalidomide, which could
then be subject to further research which might not otherwise have occurred [57]. As highlighted
above, if R&D is expected to have positive growth impacts in the economy, then any research which is
permitted by open science outputs and which is genuinely additional (for example, as compared to
duplicating existing data) contributes to this.
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As discussed in the ‘methods’ section above, macroeconomic modelling approaches have been
used to explore the potential impact of more open science approaches on the returns to R&D in the
wider economy. Specifically, they look at the impact of varying the following factors [58]:
• Accessibility, or the extent to which research findings can be accessed by users.
• Efficiency, or the extent to which R&D generates knowledge that is useful socially or economically.
The variables summarize many of the impacts described above. Such modelling requires many
large assumptions, so the results are naturally highly caveated. However, it has been estimated that a
conservative 5% increase in accessibility and efficiency in the UK could have been worth £172m per
year in increases returns to public sector R&D [23]. Because such returns are experienced year after year
(assuming the accessibility/efficiency gains are permanent), this can contribute to increased growth.
5.3. Costs and Challenges
The review also set out to see if there was evidence of open sciences approaches having negative
economic impacts. While many examples of specific additional or different costs were identified (such
as extra costs of preparing datasets for publication or payment of Article Processing Charges), none of
the overall value estimates located were negative. Going beyond direct costs, a number of ways were
proposed in which either the full benefits of open science might not be realised, or there may even be
some negative effects. However, none of the work identified attempted to put a value on these effects.
This section summarises the evidence underpinning these concerns.
There were a few suggestions that a lack of capacity within firms (and elsewhere) to make use
of outputs from open research diminished their potential to have benefits. For example, work by
Houghton, Swan and Brown, in Denmark found that the second most cited difficulty in accessing
findings was simply searching for an article online, but not being able to find it [18]. The authors suggest
that this points to a lack of higher-level information literacy skills amongst SMEs. Johnson et al. [59]
point to the potential for similar skills shortages to lead to lack of the accountability that open data
(in general) is purported to bring, and similarly the lack of awareness of the value of text mining is
highlighted as a reason for the lack of full benefits realisation via that route [17]. Huber et al. [60]
also highlight awareness and skills barriers to maximizing benefits from open data (not just research
data)—but also highlight further barriers including uncertainty around future availability of data, the
risk of imitation (as others also have access to the data), and legal and reputational risks.
Important questions are also raised about where the benefits of participating in open science
accrue, and what this might mean for the conduct of research in general. Part of this is directly related
to the rewards of commercialization. For example, while early stage research collaborations such as the
SGC have proved successful, later stage applied research (with more immediate expectation of benefits)
has been less amenable to open approaches due to firms’ perceived difficulties in protecting intellectual
property at this stage [42]. Morgan argues that if governments can provide ‘regulatory exclusivity’ to
drugs developed in an open way, this could provide an alternative form of protection [61]. There is
also the question of indirect benefits or disadvantages to researchers of conducting open research. The
potential conflict is highlighted of institutional expectations to publish in certain journals, which may
not provide open access [62]. Researchers may also be concerned about lack of credit for producing
open science outputs [63].
Some work has focused on the potential incentive for researchers to delay publication of papers
because such publication would come with a requirement to share their data, potentially diminishing
their opportunity fully exploit it [64]. The requirement to share data could even act as a disincentive to
collect it (because the researcher may expect to be able to reap the full benefits of their data collection
work). The research, a modelling study which examined researcher incentives to generate and share
data, found that if mandatory data disclosure requirements led to strategic delays in publication, this
could affect the overall (economic) welfare of the research community.
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There has been additional speculation that researchers may perceive a tension between their
institutions’ or funders’ expectations to commercialize their work, and the desire or requirement
to share findings and data openly. While in principle such a tension can be shown to exist (in the
policy statements of individual funders regarding commercialization and openness), there is as yet
no empirical evidence that researchers recognize it [65]. This review did not reveal any cost–benefit
analyses of the value to the economy of direct commercialization of publicly funded research (e.g., by
university patents or spinouts) compared to commercial exploitation of open science outputs. Finally,
in the context of open data in general, the issue was raised of whether public funding for data which is
likely to be of commercial use represents a subsidy [59]. This could be a concern if the commercial
offerings informed by the data had limited benefits for citizens.
5.4. Contextual Issues
The review revealed concentrations of open science approaches in some research areas. All the
economic evaluations of public/private open research collaborations focused on the life sciences—such
as the HGP, SGC and EBI. The common factor was a desire amongst collaborators to jointly support
(rather than duplicate) basic analysis which could subsequently be used to inform product development.
As Savage points out, efforts to extend such collaboration further into the drug discovery process
have met with less success [42]. Economic evaluations were not found for collaborations adopting
open approaches in other areas. The reasons for this are not clear—it may be that decreasing rates of
translation of basic discoveries into commercial treatments, combined with the expiry of existing drug
patents, has led pharmaceutical companies in particular to embrace open innovation approaches [66].
The sector is also subject to strong regulation which may incentivise cost sharing more than in other
sectors. However, there is no reason to think that life sciences is unique in offering the possibility for
collaboration on basic research to underpin future developments. There is the example of SPOMAN [56]
in materials science (as described briefly above), and a potential parallel in the example of the National
Geological Repository (NGR), operated by the publicly funded British Geological Survey. A Natural
Environment Research Council impact study highlighted the role of core samples made openly available
by the NGR in increasing the efficiency of drilling and geotechnical companies’ operations.
There is some evidence to suggest that economic impacts may be more likely to accrue to certain
types of commercial actor. A survey by Ware [67] found that 86% of large firm respondents reported
accessing research information through company subscriptions compared to 77% of small and medium
sized enterprises (SMEs), while use of open access sources was 68% in large firms compared to 71%
in SMEs. On a monthly basis, 27% of large firms’ respondents used an in-house information service
compared to 15% of SMEs. While Ware does not explicitly make this point, it therefore seems likely
that SMEs would stand to gain disproportionately from an increase in open access to research findings,
although this does not take into account factors such as capacity to make use of such information
(see recommendations section below).
Based on wider (informal) reading of the literature on open data business models, it is apparent
that many rely on access to real-time data such as on meteorological or transport conditions
(e.g., CityMapper8). While there are examples of real-time open research data feeds (such as LondonAir9,
which provides information on levels of air pollution), the examples identified in the review were
exclusively concerned with discrete, fixed research datasets. Even in cases where data is released on a
frequent basis (such as in the Human Genome Project, which released data within 24 h of collection),
this does not permit CityMapper-like business models, meaning this avenue for commercialization is
likely closed off for the majority of open research data. The case has also been made that the granularity
of research data reduces its commercial potential. Tim Vines, writing on the Scholarly Kitchen website,
8 https://citymapper.com/london.
9 https://www.londonair.org.uk/LondonAir/Default.aspx.
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argues that unlike social media or city data which have individuals or locations as a common thread,
most scientific datasets are ‘small and collected to answer a very specific question’ [68].
In some of the sources reviewed, there is discussion of localisation (to the country of origin) of
returns to R&D and, by inference, open access to research findings/data. For example, Houghton and
others [23] draw on previous suggestions that domestic knowledge should be weighted at 66–73%
compared to 27–33% for foreign knowledge in terms of value to the domestic economy. However,
they do not make an estimate for whether/how opening access to findings and data might affect
these weightings. At the very local level, no evidence was found regarding economic impacts in the
direct locality of research teams producing open outputs. However, as mentioned in the ‘Efficiency’
section above, firms do sometimes benefit from proximity to a local university by accessing research
information in their library. An increase in open accessibility of findings/data may make such proximity
‘workarounds’ less important.
5.5. Recommendations Captured in the Review
Many of the documents included in the review included recommendations related to increasing
positive economic impacts of open science and support further study. The majority of the
recommendations are based in general promotion of open science approaches. This might include, for
example: ensuring that funding is available for data preparation or publishing fees [23]; increasing
provision of institutional or subject repositories [23]; creating more data journals [64]; and encouraging
universities to support immediate data disclosure [64]. There was also a call for special access conditions
to research outputs for text and data mining [17]. There were some recommendations to focus attention
on awareness of the benefits of use of open science outputs [20]. Parsons et al. found that lack of search
skills and interpretive expertise was highlighted as a barrier to use of open access resources [19]. They
recommend making repositories more user-friendly (such as by simplifying user interfaces, providing
lay summaries, improving business-relevant metadata and advising academics on how to present
findings for business audiences).
Specifically in relation to economic impacts, the most common call was for more research,
monitoring and evaluation in this area, aided by identification of new metrics. As previous sections
have highlighted, there is a lack of available, comparable data on actual use of open science outputs
in a way that would allow identification of economic impacts. Research has tended to rely on either
reported use (e.g., through surveys), assumptions, or detailed case studies. Conventional research
indicators such as citation counts have little relevance to questions of economic impact, while innovation
indicators such as patents are either less relevant (in the context of open innovation) or yield little
insight on the contribution of open science outputs to the innovation. Without strong evidence for
ways in which positive economic impacts of open science can be maximized, it is difficult to design
effective support policies.
Reflecting on their evaluations of data repositories [15] and the EBI [16], the authors recommend
that such bodies collect/report more data on costs, usage and users (voluntarily), and that data be
collected in standardized ways allowing more comparative and granular analysis. Initiatives are
underway that could support this, such as Crossref’s DOI Event Tracker pilot [69]. Houghton and
Sheehan [45] called in 2006 for development of better ways of tracking the translation of knowledge
generated by R&D into economic value (and how this depends on openness of outputs), and identifying
the extent to which value is localized or spills over to other localities. While there has indeed been
progress in research on these areas (e.g., [70,71]), the review did not identify evidence on economic
impacts of open science incorporating these developments (although research is underway at McGill
university in Canada that will include consideration of local impacts [55]). Chataway et al. [62] point
out the need for a better understanding of how open access to research outputs influences firms’ use of
research, especially in the case of research data. They highlight efforts that are underway to support
this [72]. Houghton et al. make the case for research metrics and incentives that better reflect the value
of innovative open models of research communication [23]. Parsons et al. [19] provide a package of
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research recommendations including on how open access status affects search engine discoverability,
awareness and use of open materials in different organizational contexts, usability of repositories to
business users and the role of different organizational/capacities in enabling use of open materials.
5.6. Study Limitations
As with any evidence review, there is a risk that I have missed documents which highlight other
positive or negative economic impacts of open science. The study protocol, which involved a broad
search strategy combined with citation tracking and expert input/review, was designed to minimize the
chances of this—but it is still a possibility. Resource constraints meant that the screening/coding was
conducted by me alone; having a second coder would increase confidence that my decisions on what
content to include/exclude, and subsequently record, were correct. Again, however, I hope that expert
input received throughout the process of developing and conducting this review will have largely
mitigated this risk.
More broadly, in the abstract of this article I characterize the evidence in this field as patchy and
diverse. I have attempted to highlight the merits and drawbacks of different research approaches.
However, we should also bear in mind that there is the risk of systematic bias in the studies that are
conducted and/or published. The challenge of publication bias (where authors, editors, reviewers,
etc. are less likely to submit or accept ‘null’ results or those than run contrary to expectations or even
desires) is well-known [73]. We should ask whether researchers (or project funders) are as likely to
choose to examine/evaluate examples of open science that are not conspicuously successful compared
to those that are. They may be, but it is impossible to say for sure—and the techniques employed in
quantitative meta-analysis to recognize this (such as funnel plots) are not deployable in the case of this
review. We should also consider that there is likely to be a strong social desirability bias around open
science—the idea that there should be free and easy access to research findings and data is, taken at
face value, always going to be hard to dispute. Research participants might be expected to tend to
support this view. To be clear, this is not to suggest that any of the studies here have been conducted in
a biased way. Rather, we should remain alert to the possibility of ‘missing’ findings where research
scrutiny has, for various reasons, not been brought to bear—and the chance that these may be more
likely to be negative. This is another motivation for the call for more research identified in many of the
sources reviewed, and which I repeat myself.
6. Conclusions and Recommendations
6.1. Conclusions
In this paper, I have presented the results of a Rapid Evidence Assessment which set out to identify
the best available evidence of the economic impacts of open science. This section briefly summarizes
the key findings and considers their possible implications for policymakers.
Use of open science outputs (e.g., by firms) often leaves no obvious trace, so most evidence of
impacts is based on interviews, surveys, inference based on existing costs, and modelling approaches.
For example, surveys have been used to ask open data users how much time they spend searching
for data and how this is reduced when the data is open, then using salary estimates to assess labour
cost savings. Willingness to pay/accept approaches have also been used to estimate the value of free
resources. Such approaches introduce significant potential for measurement error, and assumptions on
existing costs (such as those involved in publishing findings) are often disputed.
The review identified evidence that open access to findings and data can lead to positive economic
impacts through (a) efficiency and (b) enablement, but the evidence base is patchy and diverse.
Efficiency means getting the same output from research or innovation for less input (principally public
research funding). For example, if open access publishing can be shown to allow access to research
findings for the same number of researchers for a lower overall cost, this would represent an efficiency
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saving. Enablement signifies ways in which open science approaches have led to economically
impactful activities which would have been less likely to occur in a more closed environment.
Regarding efficiency, there is indicative evidence that open access to findings/data can lead to
savings in access costs, labour costs and transaction costs. Open access should lead to cost-savings
in the university/publishing ecosystem, although (as highlighted above) modelling assumptions are
disputed and there are significant costs in transitioning to some models. Open access could reduce
costs to firms of accessing research findings (or increase availability), although this may only be a
‘latent’ savings if firms do not have capacity to access/use findings/data. Easier access to research
findings/data can reduce time required to access them, saving labour costs. There is some evidence of
reduction in transaction costs, such as material transfer agreements or for text mining (although open
access in itself does not eliminate such barriers except for non-commercial uses, where a text and data
mining copyright exception applies).
There are examples of open science enabling new products, services, companies, research and
collaborations. Multi-stakeholder collaborations such as the Human Genome Project, Structural
Genomics Consortium and European Bioinformatics Institute were enabled by agreements around
early, open release of data. The SGC revealed a compound (JQ1) which had cancer treatment potential.
GSK has gone to clinical trials with products based on this. Research that later compared the number
of patents connected to the JQ1 discovery found that after four years, 105 patents had been filed,
compared to a mean of 29 for two similar compounds which were not released openly. Three spin-out
companies have resulted from the work of the SGC, with one, Tensha Therapeutics, connected with JQ1.
It received $15m initial investment, and was acquired within a year (by Roche) for $535m. Evaluation
of the European Bioinformatics Institute found that 45% of survey respondents could not have either
found the data they access through the repository elsewhere, nor created it themselves.
Modelling studies indicate higher returns to R&D with the greater accessibility and efficiency that
open access allows. Macroeconomic modelling approaches have been used to explore the potential
impact of more open science approaches on the returns to R&D in the wider economy. Specifically,
they look at the impact of varying the following factors:
• Accessibility, or the extent to which research findings can be accessed by users.
• Efficiency, or the extent to which R&D generates knowledge that is useful socially or economically.
It was estimated in 2009 that a conservative 5% increase in accessibility and efficiency in the UK
could have been worth £172m per year in increases returns to public sector R&D. Such models include
many general assumptions.
While the review identified specific additional or different costs associated with greater openness
(such as extra costs of preparing datasets for publication), none of the overall net value estimates
located were negative. Key barriers to use of open science outputs included lack of skills capacity
in search, interpretation and text mining, and lack of clarity around where benefits accrue. There is
evidence for lack of higher-level information skills amongst SMEs. Modelling work has suggested
that mandatory data sharing could cause researchers to delay publication, affecting overall welfare
of research community. There are suggestions (but little evidence) of tension between pressures to
commercialise research and a more open approach.
There are also contextual considerations around who benefits most from open science (e.g., sectors,
SMEs vs. larger companies, types of dataset (e.g., real-time vs. static), extent of local benefits. All the
major research collaborations evaluated were in the life sciences, with collaborators jointly supporting
basic science. Later stage research collaborations have met with less success. SMEs are less likely to
have institutional subscriptions (e.g., to journals) than larger companies so could benefit more from
free access, but they may also be subject to more time and skills constraints. Research data tends to be
more static and granular than other forms of open data (e.g., public transport departures), reducing its
commercial potential. There is as yet no evidence on the role of open science in localization of benefits,
although previous general estimates have suggested that domestic knowledge has more value locally
than foreign knowledge.
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Recommendations include more research, monitoring and evaluation (incl. metrics), promoting
benefits, capacity building and making outputs more audience-friendly. There is a lack of available,
comparable data on actual use of open science outputs—where possible, repositories and open
collaborations should collect more data on costs, usage and users. A toolkit for tracking open science
impacts has recently been developed to help improve and formalize this process [74]. Research is
needed on how openness affects local vs. global return to R&D. Better understanding is needed of how
firms make use of R&D outputs, including open outputs. Consideration should be given to promoting
the benefits of open material and building capacity within firms to locate and use it. Repository design
and content could be improved to make access and use easier for a wide range of users (such as by
simplifying user interfaces, providing lay summaries, improving business-relevant metadata and
advising academics on how to present findings for business audiences).
6.2. Recommendations
The above findings demonstrate the potential of open science to provide a range of economic
benefits. On the basis of these findings, I make the following recommendations for policymakers and
research funders. These intentionally do not include measures to either increase the quantity of open
outputs available, or the usability/interoperability/etc. of these outputs—these are goals of broader
open science policy. Instead, they focus on specific ways in which the positive economic impacts of
open science might be maximized. The relevance of each recommendation will vary depending on
country context.
Promote and support new open collaborations. This review provides a number of examples of
multi-stakeholder public–private collaboration to tackle pre-competitive research challenges. These
were shown to support increases in R&D funding and development of new products and companies.
Research funders should review their areas of responsibility for subjects meeting appropriate
characteristics (i.e., basic research likely to inform subsequent innovation, multiple large private
competitors, significant regulatory burden) and promote collaborations in areas revealed as suitable.
General principles and guidance should be developed to balance a requirement for openness with
corporate partners’ commercial considerations (as for the Structural Genomics Consortium Open
Science Trust Agreement). The benefits of such collaborations should be fully explored and actively
promoted to potential commercial partners.
Streamline text and data mining. At the moment, there is an array of licence conditions even
around many open access outputs that represent barriers to text and data mining, either forbidding it
or putting up excessive transaction costs. In the UK, a text and data mining (TDM) copyright exception
has gone some way to addressing this, but still precludes commercial applications and presents other
barriers. This is also a live issue at the time of writing as debates continue around the introduction of
the new EU Directive on Copyright in the Digital Single Market. Licensing should be further simplified
with a presumption that text and data mining are possible in a wider range of applications (campaigns
are underway at the EU level to support this). Infrastructure should be put in place to support TDM
access to open access material for firms and academic libraries. The EU-funded OpenMinTeD project is
a possible example of such infrastructure [75].
Develop an open access findings/data portal targeted at business. Most infrastructure for the
outputs of research is primarily targeted at the research community, which may diminish its usability
and apparent usefulness to many companies. Dedicated portals should be developed (informed
by user research and building on lessons from previous similar initiatives) which provides a more
relevant front-end architecture, for example, categorizing open outputs by relevant business sector or
business function, and prioritizing lay summary information where available. To minimize resource
requirements this could take the form of an overlay on existing repository infrastructure. A curation
service could allow datasets or streams which appear most likely to be useful to business (determined
by characteristics such as ability to link to other datasets, real-time, etc.) to be foregrounded or even
actively pushed to suitable businesses. Such portals would also act as a focal point for promoting
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the business benefits of open science outputs and providing support and training material for those
businesses seeking to extract most value from such outputs. Models for this exist in the form of services
such as Konfer [76] and the new LORIC centre at Bishop Grosseteste University [77], and universities
could have a key role to play as neutral, trusted convenors.
Produce aligned positions and guidance on open science and commercialization. There are
potential contradictions in the aims of policies intended to encourage open science and those promoting
commercialization of research. While there is currently little evidence on the extent to which institutions
and researchers perceive contradictions, to avoid confusion there should be consistency both in the
word and intention of policy. Countries should review policies and measures intended to promote
commercialization and open science. Based on analysis of areas of complementarity and contradiction
and existing empirical evidence on how the two can most effectively be balanced, a position and
guidance should be developed which address the priorities and concerns of individual researchers,
universities, firms and the wider economy.
Continue support for open research data repositories. There is good evidence that they can
support positive economic outcomes (although this varies from case to case). Evidencing effectiveness
and impacts would be easier if more information were collected on users and uses to which data are
put (especially commercial uses which currently leave few traces). This would also allow for better
international comparison.
Continue research into new metrics and incentives. Work is ongoing to develop metrics which
can more usefully capture the wider impacts of open science outputs. This could also include
consideration of social metrics—for example, ways in which companies could indicate their use and/or
approval of a dataset (similar to a ‘like’ on Facebook). This would act as a non-scholarly equivalent to
the citation, and could provide a similar basis for research impact assessment.
Supplementary Materials: The REA protocol is available online at https://osf.io/jd3eb.
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Appendix A
Table A1. Summary of main aims and methods of the included studies.
Ref Study Aims and Approach
[15]
Beagrie, N. & Houghton, J. The Value and Impact of Data Sharing and Curation: A synthesis of three recent studies of
UK research data centres. (Jisc, 2014).
A synthesis of three similar studies, the full report for each of which was also drawn on in this review [27,35,36]. They are
treated together here as they formed part of a programme of work with very similar aims and methods.
Aims: To identify the value for, and impacts on, users and depositors of three research data repositories: The Economic and
Social Data Service, the Archaeology Data Service, and the British Atmospheric Data Centre.
Methods:
• Semi-structured interviews with a cross-section of stakeholders at each data service (n = 13–25).
• Online surveys with users (n = 299–141) and depositors (n = 42–193).
• Macro-economic modelling based on Solow–Swan model exploring impact of increasing accessibility and efficiency of
research findings on return to research and development.
• Calculation of investment value, contingent value (based on willingness-to-pay/accept), use value, welfare approaches
estimating consumer surplus and net economic value, and an activity costing approach to estimate efficiency savings.
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[16]
Beagrie, N. & Houghton, J. The value and impact of the European Bioinformatics Institute. (EMBL-EBI, 2016).
Aims: To explore the costs and cost savings of the EMBL-EBI, its value to users, and wider impacts.
Methods:
• Interviews with 29 staff and external users.
• Online survey to a convenience sample of users, 4185 usable responses (response rate 17%).
• Macro-economic modelling based on Solow–Swan model exploring impact of increasing accessibility and efficiency of
research findings on return to research and development.
• Calculation of investment value, contingent value (based on willingness-to-pay/accept), use value, welfare approaches
estimating consumer surplus and net economic value, and an activity costing approach to estimate efficiency savings.
• Three detailed impact case studies.
[24]
CEPA LLP & Mark Ware Consulting Ltd. Heading for the open road: costs and benefits of transitions in scholarly
communications. (Research Information Network (RIN), JISC, Research Libraries UK (RLUK), the Publishing
Research Consortium (PRC) and the Wellcome Trust, 2011).
This work is primarily focused on informing transitions to open access.
Aims: Provide evidence to inform scholarly communications stakeholders around dynamics of transition towards improved
access to research outputs.
Methods: Regarding impacts beyond the scholarly communications system, the Solow–Swan model approach is used to
quantify potential UK economy-wide impacts under different scenarios.
[62]
Chataway, J., Parks, S. & Smith, E. How Will Open Science Impact on University-Industry Collaborations? Foresight
and STI Governance 11, 44–53 (2017).
Aims: To consider the possible impacts of open science approaches on university-industry collaboration.
Methods: This was not an empirical study, but combines findings from previous research to develop and support arguments.
[78]
Giovani, B. Open Data for Research and Strategic Monitoring in the Pharmaceutical and Biotech Industry. Data
Science Journal 16, (2017).
Aims: to explore how to extract value from data in the biotech sector, and how companies manage intellectual property to so
as to benefit from open data while also protecting their business.
Method: Interviews and an online survey. Response rates were very small and limited methodological detail are supplied.
[79]
Houghton, J. Open Access: What are the Economic Benefits? A Comparison of the United Kingdom, Netherlands and
Denmark. (Social Science Research Network, 2009).
Applied the same approach as [23], but also encompassing the Netherland and Denmark.
[45]
Houghton, J. & Sheehan, P. The economic impact of enhanced access to research findings. (Centre for Strategic
Economic Studies, Victoria University, 2006).
Aims: To assess the value of increasing open access to research findings in OECD countries.
Methods:
• Macro-economic modelling based on Solow–Swan model exploring impact of increasing accessibility and efficiency of
research findings on return to research and development.
[18]
Houghton, J., Swan, A. & Brown, S. Access to research and technical information in Denmark. (2011).
Aims: to examine access to, and use of, technical information by knowledge-based SMEs in Denmark, as well identifying
barriers, costs and benefits.
Approach:
• 23 interviews with representatives of SMEs, some of which participated in a national incubator scheme, some of which
had not (follow-up interviews were also conducted based on survey responses.
• Online survey sent to around 1000 knowledge-based SMEs (non-random), 98 usable responses.
[23]
Houghton, J. et al. Economic implications of alternative scholarly publishing models: Exploring the costs and benefits.
(Jisc, 2009).
Aims: To identify costs and benefits of open access within scholarly publishing, as well as to the UK economy more broadly.
Methods (relating to broader economic impacts outside the scholarly communications ecosystem, which are the subject of
this review):
• Macro-economic modelling based on Solow–Swan model exploring impact of increasing accessibility and efficiency of
research findings on return to research and development.
[59]
Johnson, P. A., Sieber, R., Scassa, T., Stephens, M. & Robinson, P. The Cost(s) of Geospatial Open Data. Transactions in
GIS 21, 434–445 (2017).
This source does not focus on research data specifically, but was included as it provides a useful perspective on costs
associated with open data.
Aims: To identify externalized and unintentional impacts of open data.
Methods: This was not an empirical study, but combines findings from previous research to develop and support arguments.
[25]
Jones, M. M. et al. The Structural Genomics Consortium: A Knowledge Platform for Drug Discovery. 19 (RAND
Corporation, 2014).
Aims: To understand the nature and diversity of benefits gained through the Structural Genomics Consortium both for
partners and the wider research community including consideration of relative merits of the open vs more closed models of
operation.
Methods:
• Document and literature review.
• Semi-structured interviews with researchers/collaborators (18), current of former funders (17), and external
stakeholders (9).
• Online survey of SGC principal investigative researchers.
• Economic impact assessment of SGC outputs.
• An internal future scenarios workshop.
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[30]
Lateral Economics. Open for Business: How Open Data Can Help Achieve the G20 Growth Target. (Omidyar
Network, 2014).
Aims: Quantify and illustrate potential of open data (in general, but including research data) to meet G20’s growth target
(with focus on Australia), and to estimate what proportion of the target open data policy could deliver.
Methods:
• Macro-economic modelling based on Solow–Swan model (for Australia) exploring impact of increasing accessibility
and efficiency of research findings on return to research and development.
• Seven descriptive case studies illustrating how various impacts came about.
[17]
McDonald, D. & Kelly, U. Value and benefits of text mining. (Jisc, 2017).
Aims: To explore value and benefits of text mining under existing and alternative licensing conditions, including
consideration of costs, risks, and barriers.
Methods:
• Targeted consultation with key stakeholders.
• Desk research.
• Cost benefit analysis based on economic analysis of all evidence identified, considering cost savings and productivity
gains, potential for wider impact/innovation, efficiency and fairness of the market.
• Case studies based in part on existing research.
• Also drew on baseline evidence from other countries.
[64]
Mueller-Langer, F. & Andreoli-Versbach, P. Open access to research data: Strategic delay and the ambiguous welfare
effects of mandatory data disclosure. Information Economics and Policy 42, 20–34 (2018).
Aims: To investigate the effects of mandatory data disclosure policies on researcher decisions (e.g., around publication and
data disclosure).
Methods: Mathematical modelling of researcher decisions.
[21]
ODI. Open data means business. (Open Data Institute, 2015).
Aims: To identify use of open data by UK companies (without specific focus on research data, but use of scientific and
research data is considered).
Methods:
• Online survey with 79 responses (response rate of approximately 20%).
• Follow-up interviews with 12 companies who completed the surveys.
[19]
Parsons, D., Willis, D. & Holland, J. Benefits to the private sector of open access to higher education and scholarly
research. (Jisc, 2011).
Aims: To identify and quantify benefits to the private sector of open access to university research outputs, along with the
enablers of these benefits, mechanisms and contextual factors.
Methods:
• Systematic literature review.
• Interviews with business bodies (14), semi-structured telephone interviews with 44 enterprises, and nine detailed
enterprise profiles also based around interviews.
[49]
RAND Europe. Open Science Monitoring Impact Case Study—Structural Genomics Consortium. (European
Commission Directorate-General for Research and Innovation, 2017).
Aims: To give an overview of the impact of the Structural Genomics Consortium.
Methods: This was not an empirical study, but combines findings from previous research to describe impacts (including
economic/financial).
[26]
Sullivan, K. P., Brennan-Tonetta, P. & Marxen, L. J. Economic Impacts of the Research Collaboratory for Structural
Bioinformatics (RCSB) Protein Data Bank. RCSB Protein Data Bank (2017). doi:10.2210/rcsb_pdb/pdb-econ-imp-2017
Aims: To examine the value and economic impacts of the RCSB.
Methods: This study largely followed the research approach set out in [26]. Information on (for example) willingness to pay
and salary costs were transferred directly from that study, while usage data were based on usage of the RCSB website.
[8]
Tennant, J. P. et al. The academic, economic and societal impacts of Open Access: an evidence-based review.
F1000Research 5, 632 (2016).
Aims: To review evidence on academic, economic and social impacts of open access publishing, including brief
consideration of open research data.
Methods: This was not an empirical study, but gives examples of impacts based on a non-systematic literature review. A
short section is included considering evidence on economic impacts on non-publishers.
[22]
Tripp, S. & Grueber, M. Economic Impact of the Human Genome Project. (Battelle Memorial Institute, 2011).
Aims: To assess the economic (and other) impacts of genome sequencing.
Methods: Input-output modelling based around direct investment in the HGP, investments in follow-on research connected
with the HGP, and the wider genomics industry developed and fostered through the HGP.
[20]
Tuomi, L. Impact of the Finnish Open Science and Research Initiative (ATT). (Profitmakers Ltd., 2016).
Aims: To analyse the impacts of the Open Science and Research Initiative both nationally and internationally, and to offer
recommendations for remainder of the programme.
Methods:
• Interviews with industry representatives.
• Email questionnaires, ‘web brainstorming’ and desk research.
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Appendix B
Table A2. Search strings used to identify material in online searches, the dates of searches, the number
of records collected in each search, along with explanatory comments.
Database (+#) Date String Hits Comments
Scopus 1 20/09/17
TITLE-ABS (“open scien*” OR “open data” OR
“open research data” OR (“open access” W/1
publ* OR paper* OR journal* OR book*) OR
“open metric*”) OR TITLE (“open access”) AND
TITLE-ABS-KEY (econom* OR financ* OR cost*
OR mone*)
1926
Removed keywords from first
part as some papers with open
data tag that fact there.
Web of Science 1 20/09/17
(TS = (“open scien*” OR “open data” OR “open
research data” OR “open access publ*” OR “open
access paper*” OR “open access journal*” OR
“open access book*” OR “open metric*”) OR TI =
(“open access”)) AND TS = (econom* OR financ*
OR cost* OR mone*)
Timespan: All years. Indexes: SCI-EXPANDED,
SSCI, A&HCI, CPCI-S, CPCI-SSH, BKCI-S,
BKCI-SSH, ESCI, CCR-EXPANDED, IC.
982
Science Direct 1 20/09/17
(tak (“open scien*” OR “open data” OR “open
research data” OR “open access publ*” OR “open
access paper*” OR “open access journal*” OR
“open access book*” OR “open metric*”) OR
ttl(“open access”)) AND tak (econom* OR financ*
OR cost* OR mone*)
197 Unclear why this is so limitedcompared to Scopus.
JISC 1 (via Google) 20/09/17
“open science” OR “open access” OR “open data”
OR “open research data” site:jisc.ac.uk
filetype:pdf
60 (2 saved)
Limited to PDF, downloaded
sources judged to have a
chance of passing screening.
Gov.uk (via
Google) 20/09/17
“open science” OR “open access” OR “open data”
OR “open research data” “research”
-”open-access-land” site:gov.uk filetype:pdf
33,100 (15
saved)
Limited to PDF, downloaded
sources judged to have a
chance of passing screening.
Excluding departmental OD
strategies except BIS.
Reviewed until 5 pages passed
with no relevant material.
Innovate UK 20/09/17 N/A—hosted at gov.uk so would be picked up byabove.
AHRC 1 20/09/17
“open science” OR “open access” OR “open data”
OR “open research data” site:ahrc.ac.uk
filetype:pdf
51 (7 saved)
Limited to PDF, downloaded
sources judged to have a
chance of passing screening.
BBSRC 1 20/09/17
“open science” OR “open access” OR “open data”
OR “open research data” site:bbsrc.ac.uk
filetype:pdf
60 (3 saved)
Limited to PDF, downloaded
sources judged to have a
chance of passing screening.
ESRC 1 20/09/17
“open science” OR “open access” OR “open data”
OR “open research data” site:esrc.ac.uk
filetype:pdf
78 (1 saved)
Limited to PDF, downloaded
sources judged to have a
chance of passing screening.
EPSRC 1 20/09/17
“open science” OR “open access” OR “open data”
OR “open research data” site:epsrc.ac.uk
filetype:pdf
74 (5 saved)
Limited to PDF, downloaded
sources judged to have a
chance of passing screening.
MRC 1 20/09/17
“open science” OR “open access” OR “open data”
OR “open research data” site:mrc.ac.uk
filetype:pdf
107 (1 saved)
Limited to PDF, downloaded
sources judged to have a
chance of passing screening.
NERC 1 20/09/17 “open science” OR “open data” OR “openresearch data” site:nerc.ac.uk filetype:pdf 124 (8 saved)
Limited to PDF, downloaded
sources judged to have a
chance of passing screening.
NOTE “open access” removed
for this search as many open
access papers included and
over 2000 hits.
STFC 1 20/09/17
“open science” OR “open access” OR “open data”
OR “open research data” site:stfc.ac.uk
filetype:pdf
65 (2 saved)
Limited to PDF, downloaded
sources judged to have a
chance of passing screening.
HEFCE 1 21/9/17
“open science” OR “open access” OR “open data”
OR “open research data” site:hefce.ac.uk
filetype:pdf
10 (0 saved)
Limited to PDF, downloaded
sources judged to have a
chance of passing screening.
Google Scholar 1 21/9/17 allintitle: economic “open science” OR “openaccess” OR “open data” OR “open research data” 199 (7 saved)
Downloaded sources judged
to have a chance of passing
screening.
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Database (+#) Date String Hits Comments
Google Scholar 2 21/9/17 allintitle: impact “open science” OR “open data”OR “open research data” 90 (5 saved)
Downloaded sources judged
to have a chance of passing
screening. Removed ‘open
access’ as many articles on
citation impact.
ODI 1 21/9/17
“open science” OR “open access” OR “open data”
OR “open research data” site:theodi.org
filetype:pdf
44 (0 saved)
Downloaded sources judged
to have a chance of passing
screening.
ODI 2 21/9/17 “open research data” site:theodi.org 4 (0 saved)
DCC 1 21/9/17
impact “open science” OR “open access” OR
“open data” OR “open research data”
site:dcc.ac.uk
2480 (0 saved) First 100 hits reviewed.
Nesta 1 21/9/17
“open science” OR “open access” OR “open data”
OR “open research data” site:nesta.org.uk
filetype:pdf
143 (2 saved)
Limited to PDF, downloaded
sources judged to have a
chance of passing screening.
Nesta 2 21/9/17
impacts “open science” OR “open access” OR
“open data” OR “open research data”
site:nesta.org.uk
85 (1 saved)
Downloaded sources judged
to have a chance of passing
screening.
Centre for Open
Science 1 21/9/17
“open science” OR “open access” OR “open data”
OR “open research data” site:cos.io 120 (0 saved)
Open Research
Funders Group 1 21/9/17
“open science” OR “open access” OR “open data”
OR “open research data” site:orfg.org 5 (0 saved)
Open Access
Bibliography 1 21/9/17
Scanned through bibliography,
more on impacts on
publishers/institutions.
Universities UK 1 27/9/17
“open science” OR “open access” OR “open data”
OR “open research data”
site:universitiesuk.ac.uk filetype:pdf
38 (1 saved)
Limited to PDF, downloaded
sources judged to have a
chance of passing screening.
Universities UK 2 27/9/17
impacts “open science” OR “open access” OR
“open data” OR “open research data”
site:universitiesuk.ac.uk
29 (0 saved)
OECD Library 1 27/9/17
impacts “open science” OR “open access” OR
“open data” OR “open research data”
site:oecd-ilibrary.org
46 (4 saved)
Downloaded sources judged
to have a chance of passing
screening.
OECD Library 2 27/9/17 “open research data” OR “open data” OR “openaccess” in title/abstract. 24 (2 saved)
Search on OECD Library
advanced search.
Europa.eu 1 27/9/17
“economic impacts” “open science” OR “open
access” OR “open data” OR “open research data”
site:europa.eu
2670 (7 saved) First 50 results reviewed,progressed to next search.
Europa.eu 2 27/9/17
impacts “open science” OR “open access” OR
“open data” OR “open research data”
site:europa.eu
49,000 (12
saved) First 100 results reviewed.
Europa.eu 3 27/9/17 “open research data” site:europa.eu 2800 (1 saved)
Link saved is to EU Open
Research Data Pilot—to look
at in general.
EUA 1 27/9/17 “open science” OR “open access” OR “open data”OR “open research data” site:eua.be 514 (0 saved)
More on implications for
universities.
Google 1 27/9/17 “economic impacts” “open science” OR “openaccess” OR “open research data” filetype:pdf
81300 (6
saved)
First 80 results reviewed (until
no relevant links for several
pages).
Google 2 27/9/17 “economic impacts” “open science” OR “openaccess” OR “open research data” 184k (7 saved)
First 80 results reviewed (until
no relevant links for several
pages). Did not download
some docs which were also
identified in other searches.
Google 3 27/9/17 economic impacts “open science” OR “openaccess” OR “open research data” 59m
No additional useful docs
identified in first 50 results.
Scopus 2 27/9/17
TITLE-ABS (“open scien*” OR “open data” OR
“open research data” OR (“open access” W/1
publ* OR paper* OR journal* OR book*) OR
“open metric*”) OR TITLE (“open access”) AND
TITLE-ABS-KEY (cba OR bca OR “input-output”
OR “general equilibrium” OR “return on
investment” OR “growth accounting”)
21 Terms suggested by reviewer.
Scopus 3 5/12/17 ALL (“open access” W/2 “research data”) 90 Added to include this term.
Publications 2019, 7, 46 27 of 30
Table A2. Cont.
Database (+#) Date String Hits Comments
Scopus 4 13/4/19
TITLE-ABS-KEY (“open scien*” OR “open data”
OR “open research data” OR (“open access” W/1
publ* OR paper* OR journal* OR book*) OR
“open metric*”) OR TITLE (“open access”) AND
TITLE-ABS-KEY (econom* OR financ* OR cost*
OR mone* OR cba OR bca OR “input-output” OR
“general equilibrium” OR “return on investment”
OR “growth accounting”) AND (LIMIT-TO
(PUBYEAR, 2019) OR LIMIT-TO (PUBYEAR,
2018))
628
Update search. Items were
screened by title and abstract
in Scopus, and 11 which met
initial criteria were
downloaded.
Google 4 13/4/19 “economic impacts” “open science” OR “openresearch data” filetype:pdf
No value
provided (3
saved)
Update search. Limited to
2018 onwards. First 80 results
reviewed (until no relevant
links for several pages).
Google 5 13/4/19 “economic impacts” “open science” OR “openresearch data”
No value
provided (0
saved)
Update search. Limited to
2018 onwards. First 80 results
reviewed.
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